Characteristic | Garber 2006 | Goldberg 2005 | Hanefeld 2007 | Hällsten 2002 | Jung 2005 |
I1: rosiglitazone 4 mg + metformin 2000 C1: glibenclamide 5 mg +metformin 1000 mg | I1: rosiglitazone 8 mg + diet C1: pioglitazone 45 mg + diet | I1: rosiglitazone 4 mg + placebo I2: rosiglitazone 8 mg + placebo C1: glibenclamide + placebo | I1: rosiglitazone 8 mg C1: metformin 2 g C2: placebo | I1: rosiglitazone 4 mg + glimepiride 4 mg C1: metformin 1000 mg + glimepiride 4 mg | |
Sex [%] | I1: female35; male 65 C1: female 44; male 56 | I1: female 45; male 55 C1: female 46; male 54 | I1: female 32; male 68 I2: female 42; male 58 C1: female 30; male 70 | I1: female 29; male 71 C1: female 38; male 62 C2: female 29; male 71 | I1: female 57; male 43 C1: female 54; male 46 |
Age [years], mean (SD) | I1: 56 C1: 56 | I1: 56.3 (11.3) C1: 55.9 (10.5) | I1: 60.4 (8.2) I2: 60.6 (9.2) C1: 60.1 (8.3) | I1: 58.6 (7.5) C1: 57.8 (7.9) C2: 57.7 (7.1) | I1: 60 (8) C1: 54 (14) |
Ethnic groups [%] | I1: white 79; black 6; hispanic/latino 10; asian/pacific islander 3; other 3 C1: white 80; black 5; hispanic/latino 11; asian/pacific islander 3; other 2 | I1: white 60; hispanic 32; asian 3; african 3; other 2 C1: white 65; hispanic 29; asian 3; african 2; other 2 | I1: white 99; other 1 I2: white 97; other 3 C1: white 99.5; other 0.5 | ? | I1: korean 100 C1: korean 100 |
Duration of disease [years], mean (SD) | I1: 6 (5) C1: 5 (4) | I1: 4.0 (4.6) C1: 3.9 (4.4) | I1: 5.9 (6.0) I2: 6.0 (7.0) C1: 6.4 (6.9) | newly diagnosed | I1: 9 (5) C1 : 7 (6) |
Body mass index [kg/m2], mean (SD) | I1: 32 (5) C1: 32 (5) | I1: 32.6 (6.6) C1: 33.7 (12.9) | I1: 28.7 (3.7) I2: 28.8 (3.7) C1: 28.7 (3.9) | I1: 29.3 (3.7) C1: 29.9 (4.0) C2: 30.3 (4.5) | I1: 23.3 (2.6) C1: 24.6 (2.4) |
Pharmaco‐naive patients [%] | I1: none C1: none | Total: 8 | I1: 42 I2: 38 C1: 38 | ? | I1: none C1: none |
HbA1c [%], mean (SD) | I1: 8.4 (1.1) C1: 8.5 (1.2) | I1: 7.5 (1.2) C1: 7.6 (1.2) | I1: 8.1 (1.3) I2: 8.2 (1.4) C1: 8.2 (1.3) | I1: 6.8 (0.8) C1: 6.9 (0.7) C2: 6.3 (0.4) | I1: 9.3 (0.9) C1: 9.0 (0.8) |
Co‐morbidities [%] | ? | ? | ? | ? | ? |
Notes | ./. | ./. | ./. | SDs calculated | text table data mismatch |
Footnotes ? = unclear; I = intervention; C = control; SD = standard deviation; SE = standard error; ITT = intention‐to‐treat |